Ethos Biosciences designs, develops, and manufactures diagnostics that are accurate, repeatable, and easy to use. 

Ethos Biosciences was formed as a subsidiary of Ott Scientific in 2018 to drive healthcare innovation by providing diagnostic tools for scientists and practitioners. In November 2018, Ethos Biosciences acquired the Exocell diagnostic operation in Philadelphia from Glycadia Pharmaceuticals.

Exocell was founded in 1988 by Dr. Margo Cohen, MD/PhD to explore diagnostic and therapeutic solutions for diabetes. Exocell quickly became a leader in nephrology diagnostics with 15 patents and over 2000 research citations. The Exocell brand continues to service the top research, academic, and industrial institutions in the world. 

Ott Scientific is a family owned and operated group of specialty chemical manufacturing companies with expertise in monomers, polymers, microspheres, and reagents for the pharmaceutical, medical device, and diagnostic industries.

Biotechnology

Health Diagnostics

Medical Devices

Ethos Biosciences

Ryan Ott

Rich Quashne

This department focuses on scientific research and the development of new products and innovations.

Research and Development

This department oversees the overall direction and strategy of the organization.

Executive Leadership

This department manages financial operations and ensures customer inquiries are effectively addressed.

Finance and Support

This department oversees the testing and validation of products to ensure they meet quality standards and specifications.

Quality Assurance

This department focuses on driving revenue through strategic sales initiatives and effective marketing campaigns.

Ethos Biosciences

Org chart

Teams

Research and Development

Executive Leadership

Finance and Support

Quality Assurance

Sales and Marketing

Offices

Ethos Biosciences

Org chart

Teams

Research and Development

Executive Leadership

Finance and Support

Quality Assurance

Sales and Marketing

Offices

Related companies